SIGNS thumbnail

Transitions in Health, Employment, Social Engagement and
Inter-Generational Transfers in Singapore Study
(THE SIGNS Study) – III & IV

This study has been approved by the National University of Singapore-Institutional Review Board
(
NUS-IRB Reference Code: NUS-IRB-2022-627)

ABOUT THE SIGNS STUDY


Singapore is an ageing society. Its population of older adults, aged 60 years and older, will continue to increase in the coming decades. The Ministry of Health (MOH), Singapore has funded the Centre for Ageing Research and Education (CARE) at Duke-NUS Medical School to conduct THE SIGNS Study, a nationally-representative, longitudinal study (i.e., survey and follow-up the same set of individuals over time) of older Singaporeans. THE SIGNS Study is collecting comprehensive data on the health and wellbeing of older Singaporeans and the change in these over time.

Information collected in THE SIGNS Study includes indicators of physical and mental health and wellbeing, social engagement and participation, employment, intergenerational relationships, quality of life, and the impact of COVID-19. These national data contribute to the formulation, development, and refinement of policies and the planning of services for older adults in Singapore.

Till date, CARE has completed two waves of data collection in THE SIGNS Study. The first wave (THE SIGNS Study – I) was conducted in 2016-2017, and the second wave (THE SIGNS Study – II) was conducted in 2019. Data collection was conducted face-to-face at the residence of the participants. A total of 4549 older adults participated in THE SIGNS Study – I, and 2887 of these individuals also participated in THE SIGNS Study – II.

Now, in 2023-2024, we are collecting data for the third wave of THE SIGNS Study, i.e., THE SIGNS Study – III.

THE SIGNS STUDY - III


Recruitment is currently ongoing for THE SIGNS Study – III. National University of Singapore (NUS) has contracted a survey research company, ML Research Consultants Pte Ltd, to collect data for this study. Invitation letters informing eligible participants or households of their selection for the study will be sent out on a rolling basis through 2023 and 2024. Interviewers hired by ML Research Consultants Pte Ltd will visit eligible participants or households for data collection.

WHO HAS BEEN SELECTED TO PARTICIPATE
IN THE SIGNS STUDY - III?

Participants in the SIGNS Study – III can be either:

Previous participants of THE SIGNS Study – II who agreed to be re-contacted for participation in THE SIGNS Study – III, or 

New participants who meet all the following criteria:

  • Singapore Citizen or Permanent Resident

  • Aged 60 to 110 years

  • Living at an address provided to CARE by the Department of Statistics, Singapore

  • Not living in an institution, for health or non-health reasons, at the time of the survey


If the selected respondent is unable to respond to an initial set of screening questions due to a medical diagnosis of dementia, or does not clear the screening, then a proxy can respond on his or her behalf. This proxy must be a family member or relative of the selected respondent, aged 21 years and above and someone who is familiar with the selected respondent's health and social situation.

WHAT DOES THE SELECTED RESPONDENT
HAVE TO DO?



Initial screening


To determine if the older adult or a proxy respondent should respond to the questionnaire.


(About 10 minutes each)



Documented informed consent

To provide the older adult or proxy respondent with more information about the study, and to document his/her consent for participation in the survey.

(About 10 minutes each)



Interviewer administered questionnaire

The older adult or his/her proxy respondent will answer a survey questionnaire administered by a trained interviewer.

(About 90 minutes each)



Physical measurements

The interviewer will measure the older adult's height, weight, blood pressure, hand grip strength, walking speed, and balance.

(About 30 minutes each)

FREQUENTLY ASKED QUESTIONS (FAQ)

What is the approximate number of research participants involved?


Up to 10,000 participants across Singapore are expected to participate in THE SIGNS Study – III.


How will my privacy and the confidentiality of my research records be protected?


The survey research company contracted to carry out data collection for this study, ML Research Consultants Pte Ltd, will store all information in secured, locked locations, before it is handed over to CARE. All data collected will be kept by CARE in accordance with the NUS Research Data Management Policy. A participant's personal data will never be stored alongside their research data (i.e., responses to the screener, responses to the questionnaire, and data pertaining to the older adult’s physical measurements). Your personal data will never be used in a publication or presentation. All your research data will be coded i.e., only identified with a case number. 


Will there be reimbursement for participation?


Participants in THE SIGNS Study – III will be reimbursed with shopping vouchers in appreciation of their time. Shopping vouchers worth $40 will be given if participants respond to the questionnaire only. Alternatively, shopping vouchers worth $50 will be given if participants respond to the questionnaire and undertake the physical measurements).

I have not received an invitation letter for the study. Can I sign up for it?

Individuals or households selected for participation in THE SIGNS Study - III are being sent invitation letters on a rolling basis through 2023 and 2024. You will receive an invitation letter if you or your household is selected, and an interviewer from ML Research Consultants Pte Ltd will visit you subsequently.

 

FINDINGS AND PUBLICATIONS
FROM THE SIGNS STUDY



Some findings from THE SIGNS Study - I and THE SIGNS Study - II



SIGNS 1 page 1-1
SIGNS 1 page 2-1
THE SIGNS Study III&IV One page summary 1
THE SIGNS Study III & IV One page summary 2

Reports


IN THE PRESS AND MEDIA RELEASE

STUDY TEAM

Angelique Chan

PRINCIPAL INVESTIGATOR

Associate Professor Angelique Chan
Executive Director, CARE

Read more
Rahul

PRINCIPAL INVESTIGATOR

Associate Professor Rahul Malhotra
Deputy Director, CARE

Read more
Visaria A

CO-INVESTIGATOR

Dr. Abhijit Visaria
Principal Research Scientist, CARE

Read more
david b matchar

CO-INVESTIGATOR

Professor David Bruce Matchar
Professor, Programme in Health Services and Systems Research (HSSR)

Read more
Sumithra Suppiah

PROJECT MANAGER

Ms. Sumithra Devi Suppiah
Senior Research Associate, CARE

Read more

CONTACT US

GET IN TOUCH WITH ML RESEARCH CONSULTANTS PTE LTD

If you or your household member has been invited to participate in THE SIGNS Study – III, and should you wish to verify the identity of the interviewer, or clarify any matters about the study, or specify a time at which the interviewer should visit you, or opt out from the study, please contact ML Research Consultants Pte Ltd (the survey research company contracted to carry out data collection for the study) at:

phone
  • Telephone: 6223 7288 (Monday to Sunday from 9 am to 9pm)
  • WhatsApp: 8228 9158
email


GET IN TOUCH WITH THE SIGNS STUDY TEAM AT CARE

If you or your household member has been invited to participate in THE SIGNS Study – III, and should you wish to speak to someone from Duke-NUS Medical School about the study, please contact Ms Sumithra Devi Suppiah at:

phone          
  • Telephone: 6601 5976 (Monday to Thursday from 8.30 am to 6 pm, and Fridays from 8.30 am to 5.30 pm, except public holidays) 
  • WhatsApp: 6601 5976
email